Top Markets
#1 Black Phoenix Black Phoenix +166.51%
#2 Islamic Coin Islamic Coin +158.21%
#3 Glidr Glidr +58.56%
#4 Cryptopia Cryptopia +20.30%
#5 DOVU DOVU +19.60%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.07%
#7 Test Test +11.85%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +11.57%
#9 MarsCoin MarsCoin +10.95%
#10 stake.link stake.link +8.58%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Biostax Corp. Biostax Corp.

Biostax Corp.

BTAX
Pozycja w akcjach #41904
Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition,... Biostax Corp. is a biopharmaceutical enterprise dedicated to the acquisition, advancement, and commercialization of various pharmaceutical and biotechnology solutions. A pivotal focus lies on Lodonal, their lead investigational drug candidate, designed as a once-daily immune system modulator aimed at managing both human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Beyond this primary drug, their portfolio encompasses several innovative programs. These include a Global Telehealth platform and an early-stage Medtech initiative leveraging blockchain and smart contract technologies to enhance the security and management of prescriptions and electronic health records. Furthermore, Biostax is developing JKB-122, an experimental small molecule that acts as a long-duration toll-like receptor 4 (TLR4) antagonist, intended for the treatment of autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Another compound they address is Low Dose Naltrexone, a formula believed to offer immune-modulating advantages pertinent to conditions such as cancer, chronic pain, autoimmune disorders, and anti-aging efforts. The company also pursues development efforts for addressing hyperphosphatemia. Biostax maintains a licensing agreement with Cytocom Inc. and underwent a corporate name change from Immune Therapeutics, Inc. to its current designation in October 2023. The company's operational base is located in Winter Park, Florida.
Cena akcji
$0.0001
Ostatnia synchronizacja: 2026-08-11
Kapitalizacja rynkowa
$7.87K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-50.00%
Kraj
US
Handel Biostax Corp. (BTAX)

Kategoria

Healthcare
Historia ceny akcji dla Biostax Corp. (BTAX)
Najwyższa cena zamknięcia: $0.00 dnia 2026-08-01

Najniższa cena zamknięcia: $800.00 dnia 2010-08-01
Historia cen akcji firmy Biostax Corp. od 2010 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 -99.48%
2024 -72.33%
2023 -91.57%
2022 -66.51%
2021 -84.44%
2020 133.16%
2019 19.03%
2018 -61.96%
2017 -73.85%
2016 -72.58%
2015 30.64%
2014 -88.72%
2013 -83.85%
2012 -28.00%
2011 1,648.30%
2010 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -7.16%
KR